Testing effectiveness (Phase 2)Study completedNCT00382720What this trial is testingDocetaxel and Oxaliplatin in Gastric CancerWho this might be right forStomach Neoplasms Sanofi 275
Early research (Phase 1)Study completedNCT00098982What this trial is testingBortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer European Organisation for Research and Treatment of Cancer - EORTC 16
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00222469What this trial is testingCombination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer University of Oklahoma 50
Testing effectiveness (Phase 2)UnknownNCT01234051What this trial is testingDocetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract CancerWho this might be right forBiliary Tract Cancer Korean South West Oncology Group 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06041802What this trial is testingPembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)Who this might be right forSquamous Cell Carcinoma Merck Sharp & Dohme LLC 19
Testing effectiveness (Phase 2)UnknownNCT06178601What this trial is testingRC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forUrothelial Carcinoma Shanxi Province Cancer Hospital 36
Testing effectiveness (Phase 2)UnknownNCT01100801What this trial is testingGenomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer PatientsWho this might be right forRecurrent Gastric Cancer National University Hospital, Singapore 90
Testing effectiveness (Phase 2)UnknownNCT04826107What this trial is testingStudy of DP303c Injection in Patients With Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 196
Testing effectiveness (Phase 2)UnknownNCT05075512What this trial is testingThe Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast CancerWho this might be right forBreast Neoplasm Female Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02002312What this trial is testingPhase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal CancerWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma Radboud University Medical Center 14
Testing effectiveness (Phase 2)Study completedNCT01367665What this trial is testingSTEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell CarcinomaWho this might be right forBasal Cell Carcinoma Hoffmann-La Roche 1,232
Early research (Phase 1)Looking for participantsNCT07535112What this trial is testingLearn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D MutationWho this might be right forAdvanced/Metastatic Colorectal Adenocarcinoma Bayer 130
Testing effectiveness (Phase 2)Looking for participantsNCT07704177What this trial is testingPhase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract CancerWho this might be right forBiliary Tract Neoplasms Immunotherapy Peking Union Medical College Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601What this trial is testingElacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial CancerWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00347919What this trial is testingPazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 189
Early research (Phase 1)Looking for participantsNCT06332430What this trial is testingIntratumoral CAN2109 in Subjects With Solid TumorsWho this might be right forSolid TumorLymphoma Canwell Biotech Limited 27
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT01396707What this trial is testingTrastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOXWho this might be right forMetastatic or Recurrent Gastric AdenocarcinomaHer-2 Positive Gastric Cancer Asan Medical Center 55
Testing effectiveness (Phase 2)Study completedNCT00041106What this trial is testingGefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder CancerWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter National Cancer Institute (NCI) 50